Piers Ingram, Callio Therapeutics CEO
March 3, 2025 09:00 AM EST
Financing
Startups
Deals

AD­Cs from a decade-old Sin­ga­pore biotech find new life with $187M

Kyle LaHucik

Senior Reporter

Fra­zier Life Sci­ences and a cadre of well-known biotech in­vestors are com­ing to­geth­er for a new start­up in the an­ti­body-drug con­ju­gates field, an area of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA will con­sol­i­date to five 'shared ser­vices of­fices,' ac­cord­ing to memo to Hill staffers

Trump has tout­ed Right to Try as a life­saver. Sev­er­al gov­ern­ment staff sup­port­ing it were just let go

House and Sen­ate com­mit­tees call for brief­in­gs on health cuts from Kennedy

Trump’s broad tar­iffs ex­empt phar­ma — but for how long?

Roche plans Phase 3 for its lat­est Alzheimer’s drug at­tempt af­ter un­veil­ing more ear­ly da­ta

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times